A protein immunologically similar to the majorbasic protein ofeosinophil granules (gMBP)' is present in high concentration in the plasma of pregnant women (1). The blood level ofthis pregnancy-associated major basic protein (pMBP) increases early in gestation and plateaus by week 20 at concentrations more than 10 times normal . After another increase just before parturition, the peak level ofpMBP in pregnancy approaches the levels seen in patients with the hypereosinophilic syndrome . pMBP returns to baseline within 6 wk post partum . Unlike hypereosinophilic syndrome plasma, however, pregnancy plasma does not contain increased amounts of other eosinophil granule-derived proteins such as eosinophil-derived neurotoxin, eosinophil cationic protein, or Charcot-Leyden crystal (1). In addition, there is no eosinophilia demonstrable in peripheral blood, uterus, or placenta during pregnancy (1, 2). These observations and the immunofluorescent localization of pMBP in fetally derived X cells and giant cells in human placentae (2) suggest that pMBP is not derived from the eosinophil.
labeled IgG, 20 ng/ml in PPFE buffer, for 18 h at 4"C. Paired filters were incubated with normal mouse serum in the first stage as a negative control. The filters were extensively washed with PBS containing 0.05% Tween 20 and autoradiographed at -70'C on XAR5 film (Eastman Kodak, Rochester, NY) . Dot blot assays were performed in the same manner except that 25 pl of each column fraction was spotted directly onto the nitrocellulose .
Aptide Mapping For trypsin and cyanogen bromide digestions, ' 21 I-labeled gMBP and "'I-labeled pMBP were mixed, boiled in SDS sample buffer, and acetone precipitated in the presence of 200 hg of BSA as a carrier. Trypsin digestion was performed in 200 Al of 0.1 M NH4HCOs at pH 7 .8; a total of 60 gg ofN-tosyl-L-phenylalanyl chloromethyl ketone (TPCK) trypsin (Worthington Biochemical Corp., Freehold, NJ) added in three equal portions over 9 h of incubation at 37'C was used. Cyanogen bromide digestion at tryptophan residues was performed according to Huang et al. (13) . In each case, the radiolabeled peptides were separated by reversed-phase HPLC as described above and detected by analysis of 1-ml fractions in a dual-channel gamma counter (TM 1191; TM Analytics, Elk Grove Village, IL). The results were analyzed with a Hewlett-Packard computer (HP 9845) and a statistical graphics program (No. 15021). gMBP or pMBP (10 Fog in 0.25% acetic acid) was cleaved at aspartic acid residues by treatment at 105'C for 6 h in sealed glass vials . Cleavage products were analyzed by SDS-PAGE .
Amino Acid Analysis. NH2-terminal analysis of pMBP and sequence determination of the COOH-terminal peptide generated by cleavage in dilute acid were performed as described (11) .
Results

Purification of pMBP
Initial gel filtration of placental extracts indicated a mass of >1,000 kD (elution in the void volume of Sepharose CL-4B columns) for pMBP (data not shown) . Because this excessive size may have reflected polymerization or binding to a large car rier molecule, subsequent studies used DNase treatment to minimize complexes with DNA. However, even after nucleic acid removal, pMBP still eluted from Sepharose CL-4B columns in multiple high molecular weight peaks, a behavior similar to that ofplasma gMBP which binds to plasma proteins through ionic and disulfide bonds (4); gMBP can be resolved to the monomer, -14 kD, by reduction and alkylation and then acidification of plasma (4) . Analogous interactions for pMBP are suggested by its requirement for reduction and alkylation in order to maximize immunoreactivity with polyclonal antisera (1) and mAbs (3) and by its low molecular weight, as judged by immunodiffusion after reduction under denaturing conditions (results not shown) and by Western blot analysis (see below) .
After DNase digestion and reduction and alkylation ofplacental extracts, to minimize pMBP interactions with DNA and placental proteins, respectively, pMBP was partially purified from placental extracts or cyst fluid by affinity chromatography with mAb immobilized on Sepharose 4B. The resulting preparations were 300-700-fold enriched from placental extracts and 50-150-fold enriched from cyst fluid with 70% to almost 80% recoveries (Table 1) . Eluates were analyzed by SDS-PAGE and Western blot assay to detect immunoreactive MBP Multiple proteins were present in these eluates even though the immunoprecipitates had been washed with buffers containing high salt concentration (Fig. 1 A) . Two immunoreactive species with molecular masses of ti14 and 30 kD were present in affinity-purified cyst fluid and placental extract (Fig. 1 B) . The 30-kD molecule was replaced by a 14-kD molecule when the eluates were reduced in 8 M urea and therefore it appears to be a SDSstable polymer (data not shown). Purified eosinophil gMBP polymerizes on storage to yield a 30-kD SDS-stable species (Fig. 1 B) . On gel filtration of affinity-purified pMBP over Sephadex G-200 equilibrated with 0.01 M HCl and 0.15 M NaCl (a procedure that releases monomer gMBP from plasma protein complexes [1] ), pMBP eluted in the void volume (>400 kD) (data not shown) . This result is in contrast to the size of 14 kD shown on Western blots (Fig . 1 B) and suggests that the complexes of pMBP with placental proteins can be disrupted only by more stringent denaturing solvents. Therefore, the second purification step used gel filtration over Sepharose CL-6B in the presence of 6 M GuCl (Fig . 2) . Column fractions were screened for pMBP by dot blot assay, and Proteins separated by SDS-PAGE were transferred electrophoretically to nitrocellulose . Immunoreactive MBP was detected by using mAb anti-gMBP followed by sheep anti-mouse 121 1-la beled IgG and autoradiography. A paired blot with normal mouse serum as the first-stage antibody was negative (not shown). Lanes 1, 2, and 3 correspond to lanes 1, 2, and 3 in A ; (lane 4) eosinophil gMBP stored for 6 mo at -70°C in nonreduced state (note stable 30-kD polymer) . Sepharose CL-6B chromatography in the presence of 6 M GuCl of affinitypurified pMBP from a placental extract. Immunoreactive MBP was measured by RIA. Molecular mass markers: blue dextran (Vo), transferrin (T), BSA (B), ovalbumin (O), 0-lactoglobulin (L), cytochrome c(C), and dinitrophenyllysine (Vi) . pMBP mass = 14.7 kD.
positive fractions were dialyzed into PBS for MBP quantitation by RIA. The calculated mass for pMBP was 14.7 kD, in keeping with the results on Western blot assay ( Fig. 1) . In some cases, both the 14.7-kD molecule and the 30-kD polymer were detected in column fractions. pMBP eluted from this column with a mass of 13 .8 kD (data not shown) .
pMBP-containing fractions from Sepharose CL-6B columns were desalted, lyophilized, and subjected to reversed-phase HPLC (Fig. 3 A) . Each protein peak was collected and subjected to SDS-PAGE followed by Western blot assay to detect MBP Peak 5 gave a single band by SDS-PAGE (-15 kD) and a single spot by twodimensional gel electrophoresis (see below) . Similar results were seen with purified pMBP from cyst fluid. Fig. 4 shows the purity ofpMBP at each step ofthe purification .
Physicochemical Comparison ofpMBP and gMBP
Molecular Weight . Eosinophil gMBP has a predicted molecular weight of 14,047 based on its amino acid sequence (14) , close to the values of 14,500 by SDS-PAGE ( Fig. 1 ) and 13,800 by elution from Sepharose CL-6B in the presence of 6 M GuCl (results not shown) . The molecular weight of pMBP estimated by these procedures is also -14,000 ( Fig. 1, 2, and 3) . Further, the size similarity between gMBP and pMBP is shown by their comigration in two-dimensional gels (see below) .
Isoelectric Point. Eosinophil gMBP has an isoelectric point of 11.6 predicted by its amino acid sequence (14) . The absence of ampholytes capable ofcreating a stable gradient in this pH range precludes the exact measurement of the PI of gMBP and pMBP However, NEpHGE, the first dimension oftwo-dimensional gels, allows comparison of the relative migrations ofgMBP and pMBP in a pH gradient . Both pMBP and gMBP migrated >2 cm ahead of cytochrome c (pI = 10.6) when NEpHGE focusing was performed for 2 h (500 V), indicating a pI for each of >10.6 (data not shown) . Because gradient formation may vary in side-by-side gels, mixing experiments were performed to compare the relative migrations ofgMBP and pMBP When trace amounts of "'I-labeled pMBP were added to 5 hg of purified gMBP, the mixture was subjected to two-dimensional gel electrophoresis, and the gel was silver stained to detect gMBP and autoradiographed to detect "'I-labeled pMBP, the pMBP spot superimposed over the gMBP spot (Fig. 5, A and B) . Comigration also was found in the converse experiment with 5 lAg of purified pMBP and trace amounts of 121J_ labeled gMBP (Fig. 5, C and D) . Reversed-phase HPLC of pMBP (A) Partially purified pMBP from placental extracts was applied to a reversed-phase C18 column and eluted with a linear gradient of 90% CH3CN in 0.1% trifluoroacetic acid (buffer B) . Each peak was collected and analyzed by SDS-PAGE and Western blot assay. Hydrophobicity. The interaction of purified gMBP and pMBP with a Cts reversedphase HPLC column was used to compare the relative hydrophobicities ofthese two proteins . When differentially radiolabeled forms ofthe proteins were analyzed simultaneously, 125 1-labeled gMBP and 13 'I-labeled pMBP coeluted on reversed-phase HPLC (Fig. 6) .
Peptide Mapping . When "'I-labeled gMBP and "'I-labeled pMBP were mixed and digested with trypsin, and the peptides generated were analyzed by reversedphase HPLC, the major peptide peaks for gMBP and pMBP coincided (Fig. 7 A) . An identical result was obtained when the proteins were treated with cyanogen bromide under conditions that cleave at tryptophan (Fig. 7 B) .
The third peptide mapping protocol used dilute acid to cleave gMBP at its lone aspartic acid residue at position 71 to form two peptides that can be separated by SDS-PAGE (but not by reversed-phase HPLC) (14) . Similar treatment of pMBP produced three bands on SDS-PAGE that represented native pMBP and two cleavage products that were identical in size to the peptides generated from gMBP (Fig. 8) .
Amino Acid Sequence. N112-terminal sequence analysis was attempted on three samples of pMBP without success. Appropriate cleavage of a radiolabeled control protein indicated that this was not due to problems with the sequencer and sug- Comigration of gMBP and pMBP on two-dimensional gel electrophoresis. Mixtures of radiolabeled and unlabeled gMBP and pMBP were subjected to NEpHGE focusing in the first dimension followed by size separation by SDS-PAGE . 6 . Coelution of gMBP and pMBP on reversed-phase HPLC. A mixture of 121 1-labeled gMBP (O) and "'I-labeled pMBP ( ") was subjected to reversed-phase HPLC on a C,s column with elution by a linear gradient of 0-100% of 90% CH3CN in 0.1% trifluoroacetic acid . 1211 and "'I in the 1-ml fractions were measured in a dual-channel gamma counter. pMBP and gMBP coeluted at 54% CH3CN.
gested chemical blockage of the pMBP NH2 terminus . The peptide mapping studies outlined above suggested the possibility of determining the sequence ofthe COOHterminal peptide generated by cleavage at aspartic acid. When pMBP was digested in dilute acid and the peptide mixture was analyzed directly, a single amino acid sequence was obtained that corresponded exactly with the sequence ofresidues 72-92 of gMBP (Fig . 9 ). Discussion Two sources ofpMBP were used for purification . Fluid from placental subchorial and septal cysts is the richest source ofpMBP (up to 100 Wg/ml) (1) but is not suitable as the sole source of pMBP because of the rarity of cysts containing large amounts FIGURE 7 . Peptide maps after digestion of mixture of 121 1-labeled gMBP (O) and "'I-labeled pMBP (0). (A) Trypsin digestion. Radiolabeled peptides were separated by reversed-phase HPLC on a Cis column with a 0-70% gradient of 90% CH3CN in 0.1% trifluoroacetic acid . 1-ml fractions were collected and analyzed in a dualgamma counter. (B) Cyanogen bromide cleavage (at tryptophan). Radiolabeled peptides were separated and measured as in A . of fluid. Therefore, initial purification efforts focused on extracts of placental septal tissue. Affinity chromatography was chosen as an early purification step because of its specificity, high yield, and ability to process large volumes. Attempts to purify pMBP by affinity chromatography before removal of DNA from placental extracts were unsuccessful, probably due to the inaccessibility ofepitopes as a result ofDNA-pMBP interaction. Such complexes were demonstrated by phase partitioning and hydroxylapatite adsorption that removed both nucleic acids and pMBP (3). These complexes could not be disrupted by 2 M NaCl, which removes lysine-rich histones from DNA, but they were separated by 2 M GuCl, which removes the more tightly bound argininerich histones from DNA (15) . The results are consistent with the hypothesis that pMBP is an arginine-rich basic protein and so is chemically related to gMBP (14) . Disruption of pMBP-DNA complexes with 2 M GuCI decreased antibody binding, presumably because it caused protein denaturation, and so extracts were treated only with DNase before affinity chromatography.
Although affinity chromatography resulted in significant purification of pMBP from both placental extracts and cyst fluid, several observations indicated that the isolated pMBP was polymerized or bound to carrier proteins . Therefore, gel filtration in the presence of a denaturing solvent (6 M GuCl) was used in order to disrupt pMBP interactions with other molecules. This procedure was successful in separating monomer pMBP (14 kD) from the other proteins present, analogous to results with eosinophil gMBP in the plasma of patients with hypereosinophilic syndrome, which has been shown to polymerize and bind to plasma proteins by ionic and disulfide bonds (4) . However, those conditions (reduction, alkylation, and acidification) are inadequate to separate the pMBP found in pregnancy plasma (1) . The more rig-orous conditions necessary to disrupt pMBP-protein complexes may reflect chemical differences between gMBP and pMBP or, more probably, a higher affinity of binding of pMBP to pregnancy-associated proteins, the bulk of which are very acidic (16) .
Another similarity between pMBP and gMBP is the ability to self-polymerize. Several lines of evidence suggest that the 30-kD pMBP species seen in some extracts and cyst fluid represents a polymer: (a) the 30-kD and 14-kD species coeluted on reversed-phase HPLC, (b) the isolated 30-kD protein was replaced by a 14-kD molecule when reduced in 8 M urea, and (c) peptide mapping studies performed on preparations of pMBP contaminated with the 30-kD molecule gave the same peptide maps as the pure 14-kD protein did (data not shown) . On prolonged storage, gMBP also formed a SDS-stable 30-kD polymer.
The final purification step, reversed-phase HPLC, relied on hydrophobic interaction to separate pMBP from other proteins and resulted in a homogeneous product as determined by one-and two-dimensional gel electrophoresis . Because the placenta is such a vascular organ, the question can be raised whether the purification outlined above simply selects for contaminating gMBP from the plasma in this organ. This possibility is excluded by the yield of pMBP per milliliter of extract and by the recovery of >200 j ug of pMBP from only 19 ml of cyst fluid (Table I) . Only nanogram quantities would be expected from similar volumes of plasma because eosinophil gMBP is present in the plasma of normal humans at 200-400 ng/ml (4). Another possibility is that the pMBP isolated from the placenta is derived from eosinophils in maternal or fetal blood. In the case of septa, this possibility is unlikely because very few eosinophils are present in these tissues; in the case of the cyst fluid, this possibility can be excluded because eosinophils are not present in the cyst fluid or in the septal tissues surrounding the cysts (2) .
During pMBP purification, many characteristics of this protein were found to resemble those of gMBP In addition, gMBP and pMBP have the same molecular mass (by both SDS-PAGE and gel filtration), isoelectric point (comigration in NEpHGE), and relative hydrophobicity (coelution on reversed-phase HPLC). Sequence similarities are indicated by indistinguishable peptide maps after three separate digestions . Thus, these studies provide strong evidence that gMBP and pMBP are identical except for the blocked NH2 terminus on pMBP Furthermore, the cloning of eosinophil MBP from a human placental cDNA library supports these findings (17) .
The apparent identity of gMBP and pMBP raises important questions as to the cell source of pMBP and its biologic function in the placenta . Eosinophil gMBP is cytotoxic to mammalian cells (18, 19) and parasites (20) . It also is known to affect clotting (21) , to induce histamine release from rat mast cells and human basophils (22, 23) , and to affect the response of tracheal muscle to contractile stimuli (24, 25) . The chemical similarities between pMBP and gMBP suggest that the placental protein may have similar biologic effects. pMBP may be produced by fetally derived X cells (2) . These cells are the most invasive form of trophoblasts (26) , penetrating deep into the decidua and myometrium . Thus, the question arises as to whether a cytotoxin (like gMBP) could facilitate this invasion . In fact, early increases in plasma level of pMBP during pregnancy do correlate with implantation (27) . There is another sharp increase in plasma pMBP concentration late in pregnancy that is associated with the onset oflabor (27) . The possibility that pMBP is involved in the initiation of labor is suggested by the known effects of gMBP on tracheal smooth muscle contractility (24, 25) . The cynomolgus monkey, which also produces placental pMBP (28) , may be a model system for investigation ofthe role ofpMBP in primate reproduction.
Summary
A protein immunochemically related to the eosinophil granule major basic protein (gMBP) is found in increased concentration in the plasma of pregnant women and has been localized to placental trophoblasts by immunofluorescence . Pregnancy MBP (pMBP) is indistinguishable from gMBP in its reactivity with polyclonal antisera and a panel of 14 mouse mAbs. We report the purification of pMBP from human placenta by: (a) affinity chromatography over mAb immobilized on Sepharose, (b) gel filtration in 6 M guanidine-HCI buffer, and (c) reversed-phase HPLC. Purified pMBP and gMBP are biochemically indistinguishable in that both: (a) bind to DNA, (b) polymerize and bind to carrier proteins via disulfide linkages, (c) have a molecular weight of 14,000, (d) have isoelectric points >10.6, (e) comigrate in twodimensional gels, 0 coelute during reversed-phase HPLC on C18 columns, (g) have identical peptide maps after three different digestions, and (h) have partial amino acid sequence identity. This physicochemical identity has important implications as to the role of pMBP in human placentation .
